FDA approves Roche’s Actemra for the treatment of COVID-19 in hospitalised adults December 21, 2022January 20, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: U.S. FDA grants priority review to Roche’s…FDA grants priority review to Xolair (omalizumab)…FDA approves Roche’s Susvimo as the first and only…European Commission approves Roche’s Tecentriq as…FDA approves Roche’s Evrysdi for use in babies under…U.S. FDA approves Foundation Medicine’s…
